ASX - By Stock
|
KPO |
Re:
Ann: Non-Renounceable Entitlement Offer Results
|
|
edinamac
|
7 |
1.1K |
2 |
24/04/24 |
24/04/24 |
ASX - By Stock
|
7
|
1.1K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Monash Sleep Health Symposium
|
|
edinamac
|
13 |
1.8K |
4 |
23/04/24 |
23/04/24 |
ASX - By Stock
|
13
|
1.8K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
edinamac
|
40 |
8.6K |
6 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
40
|
8.6K
|
6
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho to present at NWR Virtual Healthcare Conference
|
|
edinamac
|
40 |
8.6K |
4 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
40
|
8.6K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
edinamac
|
90 |
28K |
5 |
12/02/24 |
12/02/24 |
ASX - By Stock
|
90
|
28K
|
5
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
edinamac
|
90 |
28K |
4 |
11/02/24 |
11/02/24 |
ASX - By Stock
|
90
|
28K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
KZIA - Banter and General Comments
|
|
edinamac
|
90 |
28K |
3 |
02/02/24 |
02/02/24 |
ASX - By Stock
|
90
|
28K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Launch of LUMOS2 Study
|
|
edinamac
|
23 |
6.8K |
1 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
23
|
6.8K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Entitlement Offer to raise $11m for Phase 3 clinical trial
|
|
edinamac
|
70 |
23K |
6 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
70
|
23K
|
6
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
edinamac
|
6 |
2.0K |
0 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
6
|
2.0K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
edinamac
|
6 |
2.0K |
1 |
30/04/23 |
30/04/23 |
ASX - By Stock
|
6
|
2.0K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Avecho channel 7
|
|
edinamac
|
41 |
8.9K |
0 |
17/04/23 |
17/04/23 |
ASX - By Stock
|
41
|
8.9K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Avecho channel 7
|
|
edinamac
|
41 |
8.9K |
1 |
17/04/23 |
17/04/23 |
ASX - By Stock
|
41
|
8.9K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Memorial Sloan Results Imminent
|
|
edinamac
|
80 |
29K |
7 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
80
|
29K
|
7
|
|
ASX - By Stock
|
KZA |
Brain Cancer
|
|
edinamac
|
2 |
934 |
3 |
30/06/22 |
30/06/22 |
ASX - By Stock
|
2
|
934
|
3
|
|
ASX - By Stock
|
SLX Energy |
Re:
Nuclear Power Related Media Thread
|
|
edinamac
|
4.7K |
2.0M |
3 |
27/06/22 |
27/06/22 |
ASX - By Stock
|
4.7K
|
2.0M
|
3
|
|
ASX - By Stock
|
KPO |
Re:
180 Markets interview
|
|
edinamac
|
11 |
3.1K |
2 |
19/10/21 |
19/10/21 |
ASX - By Stock
|
11
|
3.1K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
MEIP question
|
|
edinamac
|
6 |
1.8K |
0 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
6
|
1.8K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AB Vista to explore new TPM applications for Animal Health
|
|
edinamac
|
46 |
12K |
2 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
46
|
12K
|
2
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Appendix 3Y for 3 directors
|
|
edinamac
|
8 |
3.1K |
11 |
02/06/21 |
02/06/21 |
ASX - By Stock
|
8
|
3.1K
|
11
|
|
ASX - By Stock
|
KZA |
Re:
Examples of Suspicious Pricing Action
|
|
edinamac
|
273 |
88K |
1 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
273
|
88K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia presentation to Bell Potter Healthcare Conference
|
|
edinamac
|
27 |
5.3K |
0 |
27/11/20 |
27/11/20 |
ASX - By Stock
|
27
|
5.3K
|
0
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia's paxalisib awarded Orphan Drug Designation
|
|
edinamac
|
19 |
7.8K |
8 |
24/08/20 |
24/08/20 |
ASX - By Stock
|
19
|
7.8K
|
8
|
|
ASX - By Stock
|
KZA |
Re:
For MEIP holders.
|
|
edinamac
|
39 |
19K |
1 |
08/07/20 |
08/07/20 |
ASX - By Stock
|
39
|
19K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Avecho signs Term Sheet for Cannabinoid Supply with Purisys
|
|
edinamac
|
212 |
54K |
1 |
05/07/20 |
05/07/20 |
ASX - By Stock
|
212
|
54K
|
1
|
|
ASX - By Stock
|
SLX |
Re:
Ann: Zero-Spin Silicon Project Successfully Completes Stage One
|
|
edinamac
|
47 |
13K |
2 |
30/06/20 |
30/06/20 |
ASX - By Stock
|
47
|
13K
|
2
|
|
ASX - By Stock
|
SLX |
Re:
The State of the Nuclear Energy Industry 2020
|
|
edinamac
|
21 |
6.3K |
3 |
25/06/20 |
25/06/20 |
ASX - By Stock
|
21
|
6.3K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
For MEIP holders.
|
|
edinamac
|
39 |
19K |
3 |
30/05/20 |
30/05/20 |
ASX - By Stock
|
39
|
19K
|
3
|
|
ASX - By Stock
|
AVE |
Bit of interst
|
|
edinamac
|
1 |
1.0K |
7 |
21/05/20 |
21/05/20 |
ASX - By Stock
|
1
|
1.0K
|
7
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Change of Director's Interest Notice x4
|
|
edinamac
|
39 |
9.1K |
4 |
14/05/20 |
14/05/20 |
ASX - By Stock
|
39
|
9.1K
|
4
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Kazia EGM results
|
|
edinamac
|
53 |
21K |
2 |
24/12/19 |
24/12/19 |
ASX - By Stock
|
53
|
21K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Times up Terumo
|
|
edinamac
|
80 |
34K |
1 |
08/10/19 |
08/10/19 |
ASX - By Stock
|
80
|
34K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Times up Terumo
|
|
edinamac
|
80 |
34K |
2 |
08/10/19 |
08/10/19 |
ASX - By Stock
|
80
|
34K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics and Mylan Agree Settlement
|
|
edinamac
|
78 |
33K |
3 |
26/12/18 |
26/12/18 |
ASX - By Stock
|
78
|
33K
|
3
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Settlement Negotiations
|
|
edinamac
|
55 |
18K |
3 |
14/12/18 |
14/12/18 |
ASX - By Stock
|
55
|
18K
|
3
|
|
ASX - By Stock
|
SLX |
IQE Issue of Equity
|
|
edinamac
|
0 |
397 |
4 |
26/09/18 |
26/09/18 |
ASX - By Stock
|
0
|
397
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics Newsletter - August 2018
|
|
edinamac
|
51 |
20K |
0 |
16/08/18 |
16/08/18 |
ASX - By Stock
|
51
|
20K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: AGM Chairman's Address and CEO Presentation
|
|
edinamac
|
118 |
40K |
4 |
25/05/18 |
25/05/18 |
ASX - By Stock
|
118
|
40K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Phosphagenics Announces Results of Dairy Trial
|
|
edinamac
|
26 |
7.6K |
3 |
22/12/17 |
22/12/17 |
ASX - By Stock
|
26
|
7.6K
|
3
|
|
ASX - By Stock
|
KZA |
Re:
Ann: Consolidation/Split - NRT
|
|
edinamac
|
106 |
33K |
0 |
17/11/17 |
17/11/17 |
ASX - By Stock
|
106
|
33K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
My take on investor presentation
|
|
edinamac
|
10 |
3.5K |
5 |
04/10/17 |
04/10/17 |
ASX - By Stock
|
10
|
3.5K
|
5
|
|
ASX - By Stock
|
AVE |
Re:
My take on investor presentation
|
|
edinamac
|
10 |
3.5K |
11 |
03/10/17 |
03/10/17 |
ASX - By Stock
|
10
|
3.5K
|
11
|
|
ASX - By Stock
|
AVE |
Re:
Investor Briefings
|
|
edinamac
|
3 |
1.6K |
8 |
01/10/17 |
01/10/17 |
ASX - By Stock
|
3
|
1.6K
|
8
|
|
ASX - By Stock
|
AVE |
Re:
something to consider
|
|
edinamac
|
13 |
6.3K |
4 |
27/06/17 |
27/06/17 |
ASX - By Stock
|
13
|
6.3K
|
4
|
|
ASX - By Stock
|
AVE |
Re:
Ann: 2017 AGM Chairman and CEO Presentations
|
|
edinamac
|
50 |
20K |
2 |
01/06/17 |
01/06/17 |
ASX - By Stock
|
50
|
20K
|
2
|
|
ASX - By Stock
|
AVE |
Re:
Ann: 2017 AGM Chairman and CEO Presentations
|
|
edinamac
|
50 |
20K |
0 |
01/06/17 |
01/06/17 |
ASX - By Stock
|
50
|
20K
|
0
|
|
ASX - By Stock
|
AVE |
Re:
Ann: 2017 AGM Chairman and CEO Presentations
|
|
edinamac
|
50 |
20K |
17 |
31/05/17 |
31/05/17 |
ASX - By Stock
|
50
|
20K
|
17
|
|
ASX - By Stock
|
KZA |
Re:
10% drop holding
|
|
edinamac
|
47 |
15K |
1 |
26/05/17 |
26/05/17 |
ASX - By Stock
|
47
|
15K
|
1
|
|
ASX - By Stock
|
KZA |
Re:
nrt - mei pharma - buried in paperwork - help
|
|
edinamac
|
22 |
7.9K |
1 |
30/04/17 |
30/04/17 |
ASX - By Stock
|
22
|
7.9K
|
1
|
|
ASX - By Stock
|
AVE |
Re:
Ann: Reformulation TPM/Oxymorphone Complete
|
|
edinamac
|
49 |
12K |
3 |
12/12/16 |
12/12/16 |
ASX - By Stock
|
49
|
12K
|
3
|
|